Detalhe da pesquisa
1.
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.
Blood
; 141(13): 1610-1625, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508699
2.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
3.
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia.
Haematologica
; 108(7): 1768-1781, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519325
4.
Vascular adhesion protein-1 defines a unique subpopulation of human hematopoietic stem cells and regulates their proliferation.
Cell Mol Life Sci
; 78(23): 7851-7872, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34719737
5.
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.
Nature
; 519(7541): 102-5, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25686603
6.
8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia.
J Cell Physiol
; 234(9): 16295-16303, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770553
7.
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.
Blood
; 130(6): 789-802, 2017 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28619982
8.
Somatic MED12 Nonsense Mutation Escapes mRNA Decay and Reveals a Motif Required for Nuclear Entry.
Hum Mutat
; 38(3): 269-274, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28054750
9.
Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.
Prostate
; 76(1): 22-31, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26383637
10.
Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia.
Haematologica
; 105(3): 708-720, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31296572
11.
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia.
Blood Adv
; 8(7): 1621-1633, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197948
12.
Targeting CD33+ acute myeloid leukemia with GLK-33, a lintuzumab-auristatin conjugate with a wide therapeutic window.
Mol Cancer Ther
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561023
13.
Personalizing precision medicine: Patients with AML perceptions about treatment decisions.
Patient Educ Couns
; 115: 107883, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421687
14.
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.
Cancer Discov
; 12(2): 388-401, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789538
15.
FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML.
Sci Rep
; 11(1): 23565, 2021 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34876631
16.
Patient-tailored design for selective co-inhibition of leukemic cell subpopulations.
Sci Adv
; 7(8)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33608276
17.
Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition.
Leukemia
; 34(12): 3186-3196, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651543
18.
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century.
Blood Cancer J
; 14(1): 44, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480693
19.
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia.
Leukemia
; 33(6): 1360-1372, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568173
20.
Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid Leukaemia.
Sci Rep
; 9(1): 11796, 2019 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409822